Early initiation of ART reduces mortality among TB/HIV co-infected patients, 60,61 informing later recommendations of the WHO on starting ART for all HIV positive patients regardless of CD4 cell count as soon as possible or within the first eight weeks of beginning anti-TB regimen. This evidence concerns the gene CD4 and tuberculosis.